A synthetic peptide for use as a blocking control in assays to test for specificity of FHL3 antibody, Alternative Names: FHL3 control peptide, FHL3 antibody Blocking Peptide, Anti-FHL3 Blocking Peptide, four and a half LIM domains 3 Blocking Peptide, MGC19547 Blocking Peptide, MGC23614 Blocking Peptide, MGC8696 Blocking Peptide, SLIM2 Blocking Peptide, FHL3, FHL-3, FHL 3, FHL-3 Blocking Peptide, FHL 3 Blocking Peptide
FHL3
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP, BI
Indications d'application
Optimal conditions should be determined by the investigator
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Conseil sur la manipulation
Avoid repeated freeze/thaw cycles.
Stock
-20 °C
Stockage commentaire
Store at -20 °C long term.
Antigène
FHL3
(Four and A Half LIM Domains 3 (FHL3))
Sujet
FHL3 contains 4 LIM zinc-binding domains. It is expressed only in skeletal muscle. FHL3 association with MyoD may contribute to the regulation of MyoD-dependent transcription of muscle genes and thereby myogenesis.LIM proteins are defined by the possession of a highly conserved double zinc finger motif called the LIM domain.